Assessment of long-term alopecia after adjuvant taxane therapy for early breast cancer: a cross-sectional survey
June 2025
in “
Supportive Care in Cancer
”
The study assessed long-term alopecia in patients who underwent adjuvant taxane therapy for early breast cancer, revealing that docetaxel chemotherapy is linked to significantly higher rates of dissatisfaction and chronic alopecia compared to paclitaxel chemotherapy. These findings align with existing literature and highlight the importance of discussing potential alopecia risks with patients before starting docetaxel regimens.